Sabra Health Care Stock Current Valuation
| SBC Stock | EUR 17.88 0.05 0.28% |
Valuation analysis of Sabra Health Care helps investors to measure Sabra Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Sabra Health's price fluctuation is very steady at this time. Calculation of the real value of Sabra Health Care is based on 3 months time horizon. Increasing Sabra Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sabra stock is determined by what a typical buyer is willing to pay for full or partial control of Sabra Health Care. Since Sabra Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sabra Stock. However, Sabra Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.88 | Real 17.33 | Hype 17.88 |
The real value of Sabra Stock, also known as its intrinsic value, is the underlying worth of Sabra Health Care Company, which is reflected in its stock price. It is based on Sabra Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sabra Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sabra Health Care helps investors to forecast how Sabra stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sabra Health more accurately as focusing exclusively on Sabra Health's fundamentals will not take into account other important factors: Sabra Health Care Company Current Valuation Analysis
Sabra Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Sabra Health Current Valuation | 5.1 B |
Most of Sabra Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sabra Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Sabra Health Care has a Current Valuation of 5.1 B. This is 66.37% lower than that of the Real Estate sector and 58.58% lower than that of the REIT - Healthcare Facilities industry. The current valuation for all Germany stocks is 69.31% higher than that of the company.
Sabra Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sabra Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sabra Health could also be used in its relative valuation, which is a method of valuing Sabra Health by comparing valuation metrics of similar companies.Sabra Health is rated second in current valuation category among its peers.
Sabra Fundamentals
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 5.1 B | |||
| Shares Outstanding | 231.16 M | |||
| Shares Owned By Insiders | 1.35 % | |||
| Shares Owned By Institutions | 90.40 % | |||
| Price To Earning | 25.24 X | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 6.70 X | |||
| Revenue | 624.81 M | |||
| Gross Profit | 372.8 M | |||
| EBITDA | 216.89 M | |||
| Net Income | (77.61 M) | |||
| Cash And Equivalents | 56.81 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 2.31 B | |||
| Debt To Equity | 106.60 % | |||
| Current Ratio | 5.91 X | |||
| Book Value Per Share | 13.23 X | |||
| Cash Flow From Operations | 315.73 M | |||
| Earnings Per Share | (0.33) X | |||
| Target Price | 19.14 | |||
| Number Of Employees | 42 | |||
| Beta | 1.29 | |||
| Market Capitalization | 2.59 B | |||
| Total Asset | 5.75 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.09 % | |||
| Net Asset | 5.75 B | |||
| Last Dividend Paid | 1.2 |
About Sabra Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sabra Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sabra Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sabra Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sabra Stock
Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.